Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative efficacy of sildenafil and bosentan in newborns with persistent pulmonary hypertension
TCTR20230816006Phase 2Unknown
- Sponsor
- self
- Start
- Jan 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil, bosentan in persistent pulmonary hypertension of the newborn (PPHN), sponsored by self. Status: unknown.
02
Drugs
sildenafilbosentan
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on TCTR20230816006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230816006.